ethambutol has been researched along with Discitis in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Egwuatu, N; Jameson, A; Nasir, AZ | 1 |
| Bakhsh, WR; Mesfin, A | 1 |
| Brochot, P; Desplaces, N; Direz, G; Eschard, JP; Salmon, JH; Ziza, JM | 1 |
| Avramopoulos, I; Falagas, ME; Rafailidis, PI; Sapkas, G | 1 |
| Ader, F; Bernard, L; Carlier, R; Perronne, C; Salomon, J; Toubiana, J | 1 |
1 review(s) available for ethambutol and Discitis
| Article | Year |
|---|---|
Mycobacterium kansasii infection of the spine in a patient with sarcoidosis: a case report and literature review.
Topics: Adult; Antitubercular Agents; Diagnosis, Differential; Discitis; Drug Therapy, Combination; Ethambutol; Fever; Fractures, Compression; Humans; Immunocompromised Host; Isoniazid; Lumbar Vertebrae; Magnetic Resonance Imaging; Male; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Osteomyelitis; Sarcoidosis; Spinal Fractures | 2014 |
4 other study(ies) available for ethambutol and Discitis
| Article | Year |
|---|---|
Metagenomic next-generation sequencing identifying a rare case of
Topics: Discitis; Ethambutol; Female; High-Throughput Nucleotide Sequencing; Humans; Middle Aged; Mycobacterium; Mycobacterium Infections, Nontuberculous; Mycobacterium xenopi | 2023 |
Discitis and sacroiliitis diagnosed 15 years after iatrogenic Mycobacterium xenopi inoculation.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Clarithromycin; Cross Infection; Discitis; Disease Outbreaks; Diskectomy, Percutaneous; Drug Therapy, Combination; Ethambutol; Humans; Immunocompetence; Magnetic Resonance Imaging; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium xenopi; Rifampin; Sacroiliitis; Surgical Wound Infection; Treatment Outcome | 2012 |
Multidrug-resistant tuberculous spondylodiscitis: need for aggressive management and drug susceptibility testing of Mycobacterium tuberculosis isolates.
Topics: Anti-Bacterial Agents; Biopsy, Fine-Needle; Bone Transplantation; Cycloserine; Discitis; Drug Therapy, Combination; Ethambutol; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Streptomycin; Thoracic Vertebrae; Tomography, X-Ray Computed; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Osteoarticular; Vitamin B 6; Vitamin B Complex | 2006 |
[Cervical spondylodiscitis: one pathogen may hide another].
Topics: Anti-Bacterial Agents; Antitubercular Agents; Aza Compounds; Cervical Vertebrae; Cholecystitis; Discitis; Disease Progression; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Ethambutol; Fluoroquinolones; France; Humans; Immobilization; Isoniazid; Male; Middle Aged; Morocco; Moxifloxacin; Mycobacterium tuberculosis; Pyrazinamide; Quinolines; Radiography; Rifampin; Tuberculosis, Spinal | 2006 |